HW-211026

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameHW-211026
Drug Alias NameHW211026HW-211026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsKeratosis, Actinic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Humanwell Innovative Drug Research and Development Center Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWuhan Humanwell Innovative Drug Research and Development Center Co LtdHubei Bio-Pharmaceutical Industrial Technological Institute Inc
Inactive CompaniesN/A
Active IndicationsKeratosis, Actinic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A